Contact Us

marketing@medicilon.com

|

中

|

close search icon

中

Company Profile

Corporate Culture

Management Team

Company History

Message from the CEO

Honors and Awards

Over 20 years of experience in R&D

01 Drug Discovery

Chemistry Research

Biology Research

Early Pharmacokinetics

02 Pharmaceutical Research

Active Pharmaceutical Ingredients

Pharmaceutical preparation

Analytical Method Development and Quality Control

Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics

Drug Safety Evaluation

01 One-stop Integrated Services

Liposome Drug Development

Pharmaceutical Research

Preclinical Research

Botanical Drug Preclinical R&D

02 Innovative Drug Services

Cellular Immunotherapies

Nucleic Acid Drug

Peptide Drug Conjugate (PDC)

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection

Metabolite Identification (MetID)

Drug Forming Research

Flow Cytometry Technology

SEND Format Conversion

NanoString nCounter Detection

Routes of Drug Administration

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model

Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease

05 Advanced Preparation R&D

Inhalation drug

Ophthalmic drug

Skin Topical Preparation

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service

GLP-1 New Drug R&D Service

KRAS-targeted Drugs R&D Service

Talent Development

Campus Recruitment

Campus Recruitment

Campus Recruitment

Medicilon Events

Featured Stories

2024-07-22Medicilon Events

The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together

On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.

2024-07-22Medicilon Events

5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"

Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.

Stock Information

Investment Contact

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

Intellectual Property Protection

Clients Testimonials

Medicilon Support

U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

ABOUT
Company Profile Management Team Honors and Awards Corporate Culture

SERVICES
Drug Discovery Pharmaceutical Research Preclinical Research

PLATFORM
One-stop Integrated Services Innovative Drug R&D Services Key Technical Services for Drug R&D Drug Efficacy Evaluation for Common Diseases High-end Preparations Technology Platform Targeted Drugs R&D Services Public Services Platform

CAREERS
Talent Development Recruitment

NEWS
Medicilon Events Featured Stories Market Events Videos A.C.E.

INVESTORS
Stock Information Investment Contact

CLIENT CENTER
Intellectual Property Protection Clients Testimonials Downloads Partnerships Medicilon Support Newsletters

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 |Website Map

关闭

中

Message

Contact Us

Business Inquiry

Global：

Email:marketing@medicilon.com

+1(626)986-9880(U.S.)

0044 7790 816 954 (Europe)

China：

Email: marketing@medicilon.com.cn

Tel: +86 (21) 5859-1500

Back To Top

Online Message×

Medicilon's Market Events

News and Events

Medicilon Events Featured Stories Market Events Videos A.C.E.

HomenewsMarket Events

Market Events

Hot information：

Join Medicilon at American College of Toxicology (ACT) 2024| Join Medicilon at SITC 2024 in Houston| Join Medicilon at the 15th World ADC San Diego 2024

Medicilon will participate ACT Annual Meeting 2018

The ACT Annual Meeting will take place in West Palm Beach, FL on Nov 4-7, 2018. The American College of Toxicology (ACT) is a professional association dedicated to providing an interactive forum for the advancement

Medicilon will participate ACT Annual Meeting 2018

Medicilon will participate CBA Annual Meeting 2018

The CBA Annual Meeting will take place in Foster City, CA on Oct 6, 2018. The Chinese Bioscience Association (CBA) is a non-profit organization founded in the San Francisco Bay area in 1997. Its mission

Medicilon will participate CBA Annual Meeting 2018

Please Join Us for the Medicilon Luncheon Party

Please Join Us for the Medicilon Luncheon Party

Medicilon will participate 22nd North American ISSX Meeting

The 22nd North American ISSX Meeting will take place in Montreal, Canada from July 15-19. The ISSX meeting will bring together scientific leaders actively working on drug/xenobiotic research in diverse fields including basic and clinical

Medicilon will participate 22nd North American ISSX Meeting

Medicilon will participate CABS Annual Meeting 2018

The CABS Annual Meeting will take place in San Mateo, CA on June 23, 2018. The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is a highly

Medicilon will participate CABS Annual Meeting 2018

Medicilon will participate 2018 BIO International Conference

The 2018 BIO International Conference (BIO) will take place in Boston, MA from June 4-7. The BIO attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new

Medicilon will participate 2018 BIO International Conference

Medicilon will hold The Preclinical Research for New Drug & IND-Enabling Strategy Summit

With the rapid development of the pharmaceutical industry and the continuous increase in the demand for clinical drugs in China, the new drug R&D has entered the track of the rapid development. Under the strong

Medicilon will hold The Preclinical Research for New Drug & IND-Enabling Strategy Summit

Medicilon will participate AACR Annual Meeting 2018

The AACR Annual Meeting will take place in Chicago, IL from April 14-18. The AACR Annual Meeting is the largest cancer research meeting and exhibition in the world, with an expected attendance of more than

Medicilon will participate AACR Annual Meeting 2018

Medicilon will participate SAPA-NJ Annual Conference 2018

The SAPA-NJ Annual Conference will take place in Somerset, NJ on Oct 5-6, 2018. Sino-American Pharmaceutical Professionals Association (SAPA) was founded in 1993 and grew rapidly and has become one of the most active and well-recognized

Medicilon will participate SAPA-NJ Annual Conference 2018

Medicilon will participate CABA Investment and Entrepreneurship Symposium

The CABA Investment and Entrepreneurship Symposium will take place in Boston, MA on Sept 30. Medicilon will have a booth in the CABA Annual Conference. Both of our Chemistry and Biology VP, Dr. Huanming Chen

Medicilon will participate CABA Investment and Entrepreneurship Symposium

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy

-->